Nagy Habib is Professor of Hepato-biliary Surgery in the Dept of Surgery and Cancer at Imperial College London. He was born and received his early education in Cairo, Egypt. Later he moved to the UK to finish his medical education and completed specialised training in liver surgery. He was appointed as Consultant of Hepatobiliary Surgery at Hammersmith Hospital, in 1989. He became Professor of Hepatobiliary Surgery in 2003, and subsequently appointed as Pro-Rector of Commercial Affairs at Imperial College London. Alongside surgery, Prof Habib is actively involved in research at Imperial College London. He has had ongoing research interest in stem cells and gene therapy. He is one of the proponents of adult stem cell research for the treatment of advanced liver cancer with liver insufficiency . Professor Habib has significant academic interest and so far has published over 300 papers in the peer reviewed journals and is on editorial review board of various journals, the most notable ones being the European Journal of Cancer and the Annals of the Royal College of Surgeons of England. Professor Habib invented a radio-frequency based liver resection device which has revolutionized liver surgery by allowing liver tumour resections with minimal loss of blood. This surgical technique has been published in various scientific journals and practiced by surgeons all around the world. Moreover, he also developed two other devices Habib Probe and EUS-RFA, which are designed to treat advanced pancreatic cancer and obstructive jaundice secondary to advanced pancreatic cancer. The use of Habib Probe was first outlined by Dr. Michel Kahaleh in a pre-clinical study and has been successfully assessed in clinical studies too. The Habib 4X open and laparoscopic electrosurgical devices are distributed by AngioDynamics, Inc. In addition to liver resection surgery, the Habib 4X has been also used for various other surgeries like, partial splenectomy, distal pancreatectomy, partial nephrectomy, and myeomectomy procedures.
